D.E. Shaw & Co’s Organon & Co OGN Stock Holding History

D.E. Shaw & Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$105K	Hold	17,600	–	–	﹤0.01%	4281
2025 Q4	$126K	Hold	17,600	–	–	﹤0.01%	4383
2025 Q3	$188K	Buy	+17,600	New	+$173K	﹤0.01%	4297
2023 Q4	–	Sell	-10,000	Closed	-$174K	–	4518
2023 Q3	$174K	Buy	+10,000	New	+$209K	﹤0.01%	3789
2022 Q2	–	Sell	-7,000	Closed	-$245K	–	5643
2022 Q1	$245K	Sell	7,000 -20	-0.3%	-$684	﹤0.01%	4755
2021 Q4	$214K	Hold	7,020	–	–	﹤0.01%	4852
2021 Q3	$230K	Hold	7,020	–	–	﹤0.01%	4502
2021 Q2	$212K	Buy	+7,020	New	+$231K	﹤0.01%	4425

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

D.E. Shaw & Co's OGN Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Organon & Co (OGN) stake by 22% in Q1 2026, selling an estimated $5.58M and leaving 2,644,552 shares worth $15.8M. The position accounts for 0.01% of the portfolio, ranked #1299.

D.E. Shaw & Co first reported a position in OGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $34.6M in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

D.E. Shaw & Co held 2,644,552 shares of Organon & Co worth $15.8M as of Q1 2026.
D.E. Shaw & Co sold 742,172 Organon & Co shares in Q1 2026, an estimated $5.58M.
Organon & Co made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1299 holding.
D.E. Shaw & Co first reported a position in Organon & Co in Q2 2021 and has held it in 13 quarters since.
D.E. Shaw & Co's Organon & Co position peaked at $34.6M in Q2 2021.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.